dacarbazine has been researched along with ns 1619 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Khaitan, D; Meister, EA; Ningaraj, NS; Sankpal, UT; Vats, TS | 1 |
1 other study(ies) available for dacarbazine and ns 1619
Article | Year |
---|---|
Modulation of KCa channels increases anticancer drug delivery to brain tumors and prolongs survival in xenograft model.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzimidazoles; Blood-Brain Barrier; Brain; Brain Neoplasms; Cell Line, Tumor; Dacarbazine; Drug Delivery Systems; Female; Flow Cytometry; Glioma; Humans; Immunoblotting; Large-Conductance Calcium-Activated Potassium Channel alpha Subunits; Mice; Mice, Nude; Rats; Rats, Nude; Reverse Transcriptase Polymerase Chain Reaction; Survival Analysis; Temozolomide; Trastuzumab; Xenograft Model Antitumor Assays | 2009 |